Created in 2011 (Denmark), Galecto Biotech own 496 sister brands and 17478 competing brands. Galecto Biotech is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York Galecto Biotech belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(Galecto Biotech)
over 5 years*
USD 36.40